Valeant Parkinson’s Treatment Zelapar “Approvable” For Second Time
FDA’s latest letter on the orally disintegrating selegiline product “requests additional clarification on specific issues previously addressed by Valeant,” the company says.
FDA’s latest letter on the orally disintegrating selegiline product “requests additional clarification on specific issues previously addressed by Valeant,” the company says.